http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-006545-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 2002-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_555084a75c22ecc1d5406e6156697273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51c2f44531982036af788a7a5c881374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_485aca43bfb35afbb9a847c2c0b4664e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b2a927b2a4acd7d4debbc3741cfa52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f8268595d74e16b90df9522b00de62
publicationDate 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-006545-B1
titleOfInvention SINGLE DOSED FORM OF PHARMACEUTICAL COMPOSITION FOR EMERGENCY CONTRACEPTION AND METHODS FOR ITS PREPARATION AND APPLICATION
abstract This invention relates to a regimen for administering a composition for emergency contraception, to pharmaceutical compositions for the same purpose, to the use of levonorgestrel for the preparation of a pharmaceutical composition for the same purpose, as well as to a method for preparing such pharmaceutical compositions. According to the invention, emergency contraception is carried out using levonorgestrel as an active ingredient by administering a single dose of administration containing 1.5 ± 0.2 mg of levonorgestrel as an active ingredient, no later than 72 hours after coition. The pharmaceutical compositions for the emergency composition according to the invention contain only 1.5 ± 0.2 mg of levonorgestrel as an active ingredient in each dose of the mixture in combination with known excipients, diluents, flavoring or flavoring, stabilizing, as well as facilitating the preparation or preparation of the additives, usually used in pharmaceutical practice.
priorityDate 2001-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223

Total number of triples: 32.